- Home
- BCTXW
as 12-18-2024 9:46am EST
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
| Founded: | N/A | Country: | Canada |
| Employees: | 12 | City: | WEST VANCOUVER |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | N/A |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | N/A | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest BriaCell Therapeutics Corp. Warrant News
BCTXW Breaking Stock News: Dive into BCTXW Ticker-Specific Updates for Smart Investing
GlobeNewswire
18 hours ago
BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures
GlobeNewswire
18 hours ago
BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures
MT Newswires
5 days ago
BriaCell Therapeutics Raises $5.55 Million in an Underwritten Offering of Share Units
GlobeNewswire
5 days ago
BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering
GlobeNewswire
5 days ago
BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer
GlobeNewswire
6 days ago
BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering
MT Newswires
7 days ago
BriaCell Therapeutics Plans Public Offering; Shares Plunge After Hours
GlobeNewswire
7 days ago
BriaCell Therapeutics Announces Proposed Public Offering
Compare BCTXW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BCTXW BriaCell Therapeutics Corp. Warrant - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.